MedPath

Telehealth Treatment for Alcohol Use Disorder

Not Applicable
Recruiting
Conditions
Alcohol Use Disorder
Alcohol Dependence
Alcoholism
Registration Number
NCT05747703
Lead Sponsor
Ria Health
Brief Summary

Participants with alcohol use disorder will be randomly assigned to either the Ria Treatment Platform or a waitlist control. The Ria Treatment Platform is a telehealth approach that incorporates medical assessment, medications for alcohol use disorder, individual and group coaching, educational video modules, and a Bluetooth-enabled breathalyzer. Patients are followed for three months during which data are collected, including measures of alcohol consumption and its consequences.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
124
Inclusion Criteria
  • alcohol use disorder
Exclusion Criteria
  • inability to provide informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
percent of subjects without heavy drinkinglast four weeks

percent of subjects without heavy drinking per timeline follow-back

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Stanford University

🇺🇸

Stanford, California, United States

Stanford University
🇺🇸Stanford, California, United States
Amy Chieng, BA
Contact
Judith Prochaska, PhD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.